Skip to search formSkip to main contentSkip to account menu

5-iodo-2-aminoindan

Known as: 1H-Inden-2-amine, 2,3-dihydro-5-iodo-, 5-IAI 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Indans

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The metabolic fate of the two new psychoactive substances 2-aminoindane and N-methyl-2-aminoindane studied in vitro and in vivo to support drug testing.
The aim of this study was to characterize the in vitro and in vivo metabolism of 2-aminoindane (2,3-dihydro-1H-inden-2-amine, 2… 
2019
2019
Long-term behavioural effects of the âLegal Highâ MDMA alternative 5-IAI in adolescent rats
Previous research reports have suggested the emergence of novel club drugs as “legal high” alternatives to illegal hallucinogenic… 
2013
2013
In Vivo Occupancy of Dopamine D3 Receptors by Antagonists Produces Neurochemical and Behavioral Effects of Potential Relevance to Attention-Deficit–Hyperactivity Disorder
Dopamine D3 receptors have eluded definitive linkage to neurologic and psychiatric disorders since their cloning over 20 years… 
2012
2012
Is the 5-iodo-2-aminoindan (5-IAI) the New MDMA?
Between 1997 and 2011, more than 200 new substances have been officially notified in European Union via the Early Warning System… 
Review
2011
Review
2011
Designer Drugs / Research Chemicals / Legal Highs - A survey of recent seizures and an attempt to a more effective handling from a Swiss perspective
Since the first seizure of synthetic cannabinoids (“Spice” in 2007) on the illegal drug market in Switzerland, there has been an… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)